Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
Open Access
- 13 December 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 27 (3), 361-373
- https://doi.org/10.1093/carcin/bgi310
Abstract
Cancer of the bladder shows divergent clinical behaviour following diagnosis and it has been proposed that two major groups of tumours exist that develop via different molecular pathways. Low-grade, non-invasive papillary tumours recur frequently, but patients with these tumours do not often suffer progression of disease to muscle invasion. In contrast, tumours that are invading muscle at diagnosis are aggressive and associated with significant mortality. Molecular studies have identified distinct genetic, epigenetic and expression changes in these groups. However, it is not yet clear whether there is direct progression of low-grade superficial tumours to become invasive (a Jeckell and Hyde scenario) or whether in those patients who apparently progress from one form of the disease to the other, different tumour clones are involved and that the two tumour groups are mutually exclusive (‘chalk and cheese’). If the latter is true, then attempts to identify molecular markers to predict progression of low-grade superficial bladder tumours may be fruitless. Similarly, it is not clear whether other subgroups of tumours exist that arise via different molecular pathways. There is now a large amount of molecular information about bladder cancer that facilitates examination of these possibilities. Some recent studies provide evidence for the existence of at least one further group of tumours, high-grade superficial papillary tumours, which may develop via a distinct molecular pathway. Patients with such tumours do show increased risk of disease progression and for these there may exist a real progression continuum from non-invasive to invasive. If this is the case, definition of the molecular signature of this pathway and improved understanding of the biological consequences of the events involved will be pivotal in disease management.Keywords
This publication has 98 references indexed in Scilit:
- Multiple mechanisms downregulate CDKN1C in human bladder cancerInternational Journal of Cancer, 2004
- Alteration of the PATCHED locus in superficial bladder cancerOncogene, 2003
- Activities of MAP-Kinase Pathways in Normal Uroepithelial Cells and Urothelial Carcinoma Cell LinesExperimental Cell Research, 2003
- Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disordersEuropean Journal of Human Genetics, 2002
- Frequent FGFR3 mutations in urothelial papillomaThe Journal of Pathology, 2002
- Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) TumorsThe American Journal of Pathology, 2001
- A Sequence-Ready 840-kb PAC Contig Spanning the Candidate Tumor Suppressor Locus DBC1 on Human Chromosome 9q32–q33Genomics, 1999
- Chromosomal aberrations associated with invasion in papillary superficial bladder cancerThe Journal of Pathology, 1998
- Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 AmplificationJNCI Journal of the National Cancer Institute, 1994
- Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assayHuman Molecular Genetics, 1993